Form D · Biotechnology
Invivyd, Inc.
Waltham, MA · CIK 0001832038
Offering snapshot reported Nov 29, 2022 · SEC filing
- Reported sold
- $23.7M Offering amount: $23.7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 29, 2022 | Initial | $23,749,998 | No comparison | 1 | SEC filing |
| Apr 30, 2021 | Initial | $335,499,458 | No comparison | Not reported | SEC filing |
| Nov 12, 2020 | Initial | $79,999,816 | No comparison | 16 | SEC filing |
| Nov 12, 2020 | Initial | $49,900,000 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-466075
See Form 8-K filed by Issuer on 11-17-22 for more details. The Issuer issued a warrant to purchase up to an aggregate of 6,824,712 common shares at an exercise price of $3.48 per share, which may vest in up to three separate tranches.
Source: Form D, filed Nov 29, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jill Andersen | Executive |
| Tamsin Berry | Director |
| Philip Chase | Director |
| Lynn Connolly | Executive |
| Rebecca Dabora | Executive |
| Fred Driscoll | Executive |
| Marc Elia | Director |
| Tillman U. Gerngross | Director, Executive |
| Halley Gilbert | Executive |
| Jane Henderson | Executive |
| David Hering | Director, Executive |
| Ellie Hershberger | Executive |
| Tom Heyman | Director |
| Eric Kimble | Executive |
| Christine Lindenboom | Director |
| Howard Mayer | Director |
| Terrance Mc Guire | Director |
| Terry Mc Guire | Director |
| Clive A. Meanwell | Director |
| Ajay Royan | Director |
| Rene Russo | Director |
| Laura Walker | Executive |
| Michael S. Wyzga | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1601 Trapelo Road Suite 178
Waltham, MA, 02451
Waltham, MA, 02451